X-Zyme Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Employees
  • 1
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

X-Zyme General Information


Developer and supplier of innovative enzymes and chiral products for the biocatalyst market. The company has developed a portfolio of enzyme libraries, chiral intermediates and single-enantiomer form of drugs, including chiral alcohols, diols and amins.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Johnson Matthey Catalysis & Chiral Technologies
Primary Office
  • Life Science Center
  • Merowingerplatz 1A
  • 40225 Duesseldorf
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

X-Zyme Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore X-Zyme‘s full profile, request access.

Request a free trial

X-Zyme Executive Team (1)

Name Title Board Seat Contact Info
Shukry Na'amnieh Managing Director and Chief Executive Officer
To view X-Zyme’s complete executive team members history, request access »

X-Zyme Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial